SCHEMBL2907595

SCHEMBL2907595

NC(=O)C1CCN(CC(=O)Nc2cn(CCCNc3ccc([N+](=O)[O-])c(N)n3)cc2-c2ccc(Cl)cc2Cl)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 4/20 0.46
GSK3A P49840 3/20 0.46
POLB P06746 3/20 0.43
CDK1 P06493 2/20 0.41
CCNB2 O95067 1/20 0.40
CCNB1 P14635 1/20 0.40
CCNB3 Q8WWL7 1/20 0.40
MAPT P10636 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ALDH1A1 P00352 4/20 0.39
KDM4E B2RXH2 1/20 0.36
TSHR P16473 1/20 0.36
HSD17B10 Q99714 1/20 0.36
F10 P00742 1/20 0.36
MEN1 O00255 1/20 0.36
HTT P42858 1/20 0.36
KMT2A Q03164 1/20 0.36
RECQL P46063 1/20 0.36
MAPK1 P28482 1/20 0.35
ATM Q13315 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2911992 0.95 GSK3B (0.46) GSK3BGSK3APOLBCDK1CCNB2
SCHEMBL2912784 0.92 GSK3B (0.49) GSK3BGSK3APOLBCDK1CCNB2
SCHEMBL2910746 0.91 GSK3B (0.48) GSK3BGSK3APOLBCDK1CCNB2
SCHEMBL2908076 0.90 GSK3B (0.44) GSK3BGSK3APOLBCDK1CCNB2
SCHEMBL2914179 0.90 GSK3B (0.47) GSK3BGSK3APOLBCDK1CCNB2
SCHEMBL2909848 0.88 GSK3B (0.45) GSK3BGSK3APOLBCDK1CCNB2
SCHEMBL2911693 0.88 GSK3B (0.45) GSK3BGSK3APOLBCDK1CCNB2
SCHEMBL2909820 0.88 GSK3B (0.45) GSK3BGSK3APOLBCDK1CCNB2
SCHEMBL2911760 0.88 GSK3B (0.45) GSK3BGSK3APOLBCDK1CCNB2
SCHEMBL2913211 0.85 POLB (0.46) GSK3BGSK3APOLBL3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537099-B1 PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 NOVARTIS VACCINES & DIAGNOSTIC (US) 2010-08-11 EP disclosed